RBM45 is an m6A-binding protein that affects neuronal differentiation and the splicing of a subset of mRNAs.
Cell Rep, 2022/08/30;40(9):111293.
Choi SH[1], Flamand MN[1], Liu B[1], Zhu H[1], Hu M[2], Wang M[2], Sewell J[1], Holley CL[3], Al-Hashimi HM[4], Meyer KD[5]
Affiliations
PMID: 36044854DOI: 10.1016/j.celrep.2022.111293
Impact factor: 9.995
Abstract
N6-methyladenosine (m6A) is deposited co-transcriptionally on thousands of cellular mRNAs and plays important roles in mRNA processing and cellular function. m6A is particularly abundant within the brain and is critical for neurodevelopment. However, the mechanisms through which m6A contributes to brain development are incompletely understood. RBM45 acts as an m6A-binding protein that is highly expressed during neurodevelopment. We find that RBM45 binds to thousands of cellular RNAs, predominantly within intronic regions. Rbm45 depletion disrupts the constitutive splicing of a subset of target pre-mRNAs, leading to altered mRNA and protein levels through both m6A-dependent and m6A-independent mechanisms. Finally, we find that RBM45 is necessary for neuroblastoma cell differentiation and that its depletion impacts the expression of genes involved in several neurodevelopmental signaling pathways. Altogether, our findings show a role for RBM45 in controlling mRNA processing and neuronal differentiation, mediated in part by the recognition of methylated RNA.
Keywords: CP: Developmental biology; CP: Molecular biology; N(6)-methyladenosine; RBM45; RNA splicing; epitranscriptomics; m(6)A; neurobiology; neurodevelopment
MeSH terms
More resources
Full text:
Europe PubMed Central; PubMed Central
EndNote: Download